Aerovate slashes workforce after failed Phase IIb trial [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Yahoo! Finance
The Massachusetts-based biotech announced the downsizing in an SEC filing where Aerovate said it expects to incur costs of about $5.6m related to the layoffs. These costs are expected to be incurred in the third and fourth quarters of 2024. The company also added that it expects all of its workforce to be cut in the coming months. On 17 June, Aerovate shut down its Phase II/III IMPAHCT trial (NCT05036135) after the Phase IIb section did not meet its primary endpoint for improvement in PAH compared to placebo for any of the studied doses. AV-101—an inhaled version of the drug imatinib—also failed to show meaningful improvements in the secondary endpoint of change in six minute walk distance. The Phase III and long-term extension arms (NCT05557942) were consequently stopped, with Aerovate's stock price plummeting over 90% following the announcement. PAH is a condition characterised by high blood pressure, leading to strain on the heart and reduced oxygenation. Competition in the PA
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Clariti Strategic Advisors expands investment advisory team [Wealth Professional (Canada)]Wealth Professional
- Navidea drops rheumatoid arthritis programme after failed Phase III trial [Yahoo! Finance]Yahoo! Finance
- CLARITI STRATEGIC ADVISORS™ ANNOUNCES THE ADDITION OF THREE NEW TEAM MEMBERS [Yahoo! Finance]Yahoo! Finance
- Global Ophthalmic Devices Market Analysis Report 2024-2032 Featuring Johnson & Johnson, Topcon, Canon, Alcon, STAAR Surgical, Glaukos, IRIDEX, Carl Zeiss [Yahoo! Finance]Yahoo! Finance
- India Glucose Monitoring Devices Market, Competition, Forecasts and Opportunities, 2030F: Increased Use of Smart Glucometers and Growth in the Use of Non-Invasive Glucose Monitoring Devices [Yahoo! Finance]Yahoo! Finance
JNJ
Earnings
- 4/16/24 - Beat
JNJ
Sec Filings
- 6/25/24 - Form 11-K/A
- 6/24/24 - Form 11-K
- 6/24/24 - Form 11-K
- JNJ's page on the SEC website